Farallon Capital Management, L.L.C.
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Farallon Capital Management, L.L.C. reported 140 stock positions worth $16.6 billion. Its top holding was Hess (HES) at 6.0% of the portfolio, followed by Unitedhealth (UNH, 5.0%) and Salesforce (CRM, 4.6%). Compared with Q1 2024, it opened 19 new positions, sold out of 23, added to 32 and reduced 39. The biggest buy was a new position in Walt Disney (DIS) and the biggest sale an exit from Pioneer Natural Resources (PXD).
- Most Recent 13F
- Q2 2026
- Location
- SAN FRANCISCO, CA
- CIK
- 0000909661
- Portfolio Value
- $16.6B (Q2 2024)
- SEC Filing
- 0000908834-24-000200 ↗ filed Aug 14, 2024
Holdings Value
Holdings 140 stocks · $16.6B
| HES Hess Corp. | 6.03% | 6,780,000 | $1.0B | Add +5.4% |
| UNH Unitedhealth Group Inc. | 4.97% | 1,618,200 | $824.1M | Reduce -4.9% |
| CRM Salesforce Inc. | 4.57% | 2,946,838 | $757.6M | Add +51.0% |
| IQV Iqvia Holdings Inc. | 3.72% | 2,923,032 | $618.0M | Add +3.1% |
| EXEL Exelixis Inc. | 3.67% | 27,102,500 | $609.0M | Add +1.6% |
| ARMK Aramark | 3.47% | 16,929,237 | $575.9M | Reduce -5.0% |
| AON Aon PLC Class A | 3.32% | 1,875,200 | $550.5M | Add +196.7% |
| MSFT Microsoft Corp. | 3.24% | 1,202,778 | $537.6M | Reduce -0.7% |
| NYT New York Times Co. Class A | 3.06% | 9,919,840 | $508.0M | Reduce -11.3% |
| NTRA Natera Inc. | 2.91% | 4,460,557 | $483.0M | Add +13.6% |
| NDAQ Nasdaq Inc. | 2.73% | 7,506,719 | $452.4M | Reduce -11.0% |
| TRU Transunion | 2.70% | 6,035,119 | $447.6M | Reduce -5.0% |
| CTLT Catalent Inc. | 2.58% | 7,600,000 | $427.3M | Add +198.0% |
| INTU Intuit Inc. | 2.49% | 629,097 | $413.4M | Add +17.1% |
| TMO Thermo Fisher Scientific Inc. | 2.46% | 739,156 | $408.8M | Reduce -7.3% |
| RVMD Revolution Medicines Inc. | 2.28% | 9,757,692 | $378.7M | Add +30.0% |
| SRPT Sarepta Therapeutics Inc. | 2.19% | 2,295,000 | $362.6M | Reduce -6.5% |
| NOW ServiceNow Inc. | 2.15% | 454,050 | $357.2M | Add +14.9% |
| DIS The Walt Disney Co. filed as DISNEY WALT CO | 2.14% | 3,582,168 | $355.7M | New |
| SPGI S&P Global Inc. | 2.10% | 781,934 | $348.7M | Reduce -1.5% |
| WAB Wabtec Corp. | 2.09% | 2,189,498 | $346.1M | Reduce -25.9% |
| CBRE CBRE Group Inc. Class A | 2.03% | 3,773,000 | $336.2M | Reduce -9.8% |
| GOOG Alphabet Inc. Class C | 1.99% | 1,796,540 | $329.5M | Reduce -46.2% |
| BSX Boston Scientific Corp. | 1.91% | 4,109,157 | $316.4M | Reduce -10.6% |
| ADI Analog Devices Inc. | 1.77% | 1,284,800 | $293.3M | Reduce -16.5% |
| ABNB Airbnb Inc. Class A | 1.55% | 1,701,000 | $257.9M | Add +5.8% |
| AGIO Agios Pharmaceuticals Inc. | 1.47% | 5,654,502 | $243.8M | Add +1.1% |
| V Visa Inc. Class A | 1.30% | 821,886 | $215.7M | Add +20.7% |
| YMM Full Truck Alliance -SPN ADR | 1.25% | 25,850,303 | $207.8M | Reduce -1.6% |
| MA Mastercard Inc. Class A | 1.23% | 462,771 | $204.2M | Reduce -9.8% |
| PTGX Protagonist Therapeutics Inc. | 1.22% | 5,840,773 | $202.4M | Add +1.8% |
| HCP Hashicorp Inc. Class A | 1.20% | 5,905,000 | $198.9M | New |
| HWM Howmet Aerospace Inc. | 1.19% | 2,541,839 | $197.3M | Reduce -25.5% |
| SHW The Sherwin-Williams Co. | 1.16% | 647,550 | $193.2M | Reduce -14.1% |
| AZN Astrazeneca PLC-Spons ADR | 1.13% | 2,409,718 | $187.9M | Add +65.1% |
| BEAM Beam Therapeutics Inc. | 1.12% | 7,913,123 | $185.4M | Add +75.4% |
| LNTH Lantheus Holdings Inc. | 1.10% | 2,279,227 | $183.0M | Add +53.7% |
| SRCL Stericycle Inc. | 0.90% | 2,560,000 | $148.8M | New |
| CNC Centene Corp. | 0.87% | 2,168,175 | $143.8M | Reduce -16.9% |
| MASI Masimo Corp. | 0.85% | 1,119,563 | $141.0M | Reduce -24.8% |
| AMED Amedisys Inc. | 0.72% | 1,308,500 | $120.1M | Add +29.8% |
| EDU New Oriental Educatio-SP ADR | 0.69% | 1,469,590 | $114.2M | Add +139.0% |
| THC Tenet Healthcare Corp. | 0.55% | 687,442 | $91.5M | Add +7.8% |
| ANSS Ansys Inc. | 0.49% | 255,000 | $82.0M | No change |
| LBPH Longboard Pharmaceuticals Inc. | 0.48% | 2,940,500 | $79.5M | No change |
| BHVN Biohaven Ltd. | 0.47% | 2,248,000 | $78.0M | Add +181.3% |
| AMGN Amgen Inc. | 0.44% | 232,000 | $72.5M | New |
| GERN Geron Corp. | 0.43% | 16,837,000 | $71.4M | Add +124.6% |
| BEKE Ke Holdings Inc.-ADR filed as KE HLDGS INC | 0.40% | 4,740,833 | $67.1M | No change |
| X United States Steel Corp. | 0.39% | 1,710,000 | $64.6M | Reduce -46.4% |
| ICLR Icon PLC | 0.34% | 178,200 | $55.9M | Reduce -0.8% |
| COR Cencora Inc. | 0.33% | 242,800 | $54.7M | Reduce -27.3% |
| CERE Cerevel Therapeutics Holding | 0.29% | 1,190,000 | $48.7M | Add +11.9% |
| SIMO Silicon Motion Technol-ADR | 0.28% | 567,534 | $46.0M | Reduce -33.7% |
| UTHR United Therapeutics Corp. | 0.27% | 143,000 | $45.6M | Add +30.0% |
| INSM Insmed Inc. | 0.23% | 568,000 | $38.1M | New |
| PGNY Progyny Inc. | 0.23% | 1,308,500 | $37.4M | Add +120.8% |
| FLUT Flutter Entertainment PLC-Di | 0.22% | 200,800 | $36.6M | New |
| CRSP Crispr Therapeutics AG | 0.17% | 530,000 | $28.6M | New |
| ENTA Enanta Pharmaceuticals Inc. | 0.16% | 2,095,000 | $27.2M | No change |
| CHX Championx Corp. | 0.16% | 785,000 | $26.1M | New |
| AXONICS INC | 0.15% | 370,000 | $24.9M | Add +64.4% |
| LQDA Liquidia Corp. | 0.15% | 2,055,000 | $24.7M | No change |
| CRNX Crinetics Pharmaceuticals Inc. | 0.13% | 497,000 | $22.3M | Add +9840.0% |
| PCVX Vaxcyte Inc. | 0.13% | 290,000 | $21.9M | Reduce -23.2% |
| DFS Discover Financial Services | 0.13% | 160,000 | $20.9M | No change |
| SVRA Savara Inc. | 0.11% | 4,560,000 | $18.4M | Add +90.5% |
| VYGR Voyager Therapeutics Inc. | 0.11% | 2,292,000 | $18.1M | No change |
| CNTA Centessa Pharmaceuticals Ltd. | 0.11% | 1,996,000 | $18.0M | Add +438.0% |
| SYRE Spyre Therapeutics Inc. | 0.09% | 666,000 | $15.7M | Add +42.9% |
| TAL Tal Education Group- ADR | 0.09% | 1,365,000 | $14.6M | No change |
| ZYME Zymeworks Inc. | 0.08% | 1,601,000 | $13.6M | No change |
| PCG P G & E Corp. | 0.07% | 692,323 | $12.1M | Reduce -45.6% |
| GDS GDS Holdings Ltd. - ADR filed as GDS HLDGS LTD | 0.07% | 1,226,133 | $11.4M | Add +72.7% |
| ELEV Elevation Oncology Inc. | 0.06% | 3,598,418 | $9.7M | Reduce -7.4% |
| TWST Twist Bioscience Corp. | 0.06% | 192,000 | $9.5M | New |
| RIO Rio Tinto PLC-Spon ADR | 0.05% | 137,500 | $9.1M | No change |
| VTYX Ventyx Biosciences Inc. | 0.04% | 3,170,000 | $7.3M | No change |
| ROIV Roivant Sciences Ltd. | 0.04% | 673,000 | $7.1M | Reduce -25.1% |
| TECX Tectonic Therapeutic Inc. | 0.04% | 431,010 | $7.1M | New |
| BBOT Bridgebio Oncology Therapeut filed as HELIX ACQUISITION CORP II | 0.04% | 600,000 | $6.1M | No change |
| MAC COPPER LTD filed as METALS ACQUISITION LIMITED | 0.03% | 410,197 | $5.6M | Add +160.4% |
| CYTK Cytokinetics Inc. | 0.03% | 102,400 | $5.5M | No change |
| MGX Metagenomi Therapeutics Inc. | 0.03% | 1,343,201 | $5.5M | No change |
| NVAX Novavax Inc. | 0.03% | 377,250 | $4.8M | Reduce -66.6% |
| RARE Ultragenyx Pharmaceutical Inc. | 0.02% | 99,000 | $4.1M | No change |
| PRME Prime Medicine Inc. | 0.02% | 750,000 | $3.9M | No change |
| COGT Cogent Biosciences Inc. | 0.02% | 425,161 | $3.6M | Reduce -8.0% |
| IVCP Swiftmerge Acquisition Cor-A | 0.02% | 300,000 | $3.3M | No change |
| BACA Berenson Acquisition Co. Class A | 0.02% | 285,715 | $3.0M | No change |
| BDSX Biodesix Inc. | 0.02% | 1,878,175 | $2.9M | New |
| ARYD Arya Sciences Acquisition-A | 0.01% | 200,000 | $2.3M | No change |
| NRIX Nurix Therapeutics Inc. | 0.01% | 108,799 | $2.3M | New |
| AMLX Amylyx Pharmaceuticals Inc. | 0.01% | 1,150,221 | $2.2M | No change |
| SMLP Summit Midstream Partners LP | 0.01% | 58,214 | $2.1M | No change |
| GATE Marblegate Acquisition Cor-A | 0.01% | 150,000 | $1.6M | No change |
| VNET Vnet Group Inc.-ADR | 0.01% | 650,000 | $1.4M | No change |
| QTRX Quanterix Corp. | 0.01% | 80,000 | $1.1M | Reduce -83.0% |
| FORTE BIOSCIENCES INC | 0.01% | 1,810,455 | $972K | No change |
| MDGL Madrigal Pharmaceuticals Inc. | 0.01% | 3,319 | $930K | No change |
| VEEV Veeva Systems Inc. Class A | 0.00% | 3,622 | $663K | New |
| SAGE Sage Therapeutics Inc. | 0.00% | 42,800 | $465K | No change |
| BPMC Blueprint Medicines Corp. | 0.00% | 4,000 | $431K | No change |
| TVRD Cara Therapeutics Inc. | 0.00% | 1,556,251 | $402K | No change |
| KRYS Krystal Biotech Inc. | 0.00% | 2,000 | $367K | No change |
| AXSM Axsome Therapeutics Inc. | 0.00% | 4,000 | $322K | No change |
| HCA HCA Healthcare Inc. | 0.00% | 1,000 | $321K | No change |
| IMVT Immunovant Inc. | 0.00% | 12,000 | $317K | New |
| GKOS Glaukos Corp. | 0.00% | 2,600 | $308K | No change |
| TMDX Transmedics Group Inc. | 0.00% | 2,000 | $301K | New |
| MMSI Merit Medical Systems Inc. | 0.00% | 3,000 | $258K | No change |
| EHC Encompass Health Corp. | 0.00% | 3,000 | $257K | No change |
| BTSG Brightspring Health Services | 0.00% | 22,000 | $250K | No change |
| GMED Globus Medical Inc. Class A | 0.00% | 3,600 | $247K | New |
| ARQT Arcutis Biotherapeutics Inc. | 0.00% | 26,000 | $242K | Reduce -98.5% |
| HQY Healthequity Inc. | 0.00% | 2,800 | $241K | No change |
| MRUS Merus NV | 0.00% | 4,000 | $237K | New |
| APLS Apellis Pharmaceuticals Inc. | 0.00% | 6,000 | $230K | No change |
| IONS Ionis Pharmaceuticals Inc. | 0.00% | 4,800 | $229K | Reduce -99.3% |
| HUM Humana Inc. | 0.00% | 600 | $224K | Reduce -98.8% |
| ACLX Arcellx Inc. | 0.00% | 4,000 | $221K | No change |
| CHE Chemed Corp. | 0.00% | 400 | $217K | No change |
| SBRA Sabra Health Care REIT Inc. | 0.00% | 14,000 | $216K | No change |
| DYN Dyne Therapeutics Inc. | 0.00% | 6,000 | $212K | New |
| IOVA Iovance Biotherapeutics Inc. | 0.00% | 26,000 | $209K | No change |
| SNDX Syndax Pharmaceuticals Inc. | 0.00% | 10,000 | $205K | No change |
| RNAM Avidity Biosciences Inc. | 0.00% | 5,000 | $204K | Reduce -99.2% |
| HIMS Hims & Hers Health Inc. | 0.00% | 10,000 | $202K | Reduce -99.4% |
| RCM R1 RCM Inc. | 0.00% | 16,000 | $201K | No change |
| CGC Canopy Growth Corp. | 0.00% | 30,000 | $194K | New |
| PACB Pacific Biosciences of Calif | 0.00% | 135,000 | $185K | Reduce -96.4% |
| ALT Altimmune Inc. | 0.00% | 27,600 | $184K | Reduce -94.1% |
| GRFS Grifols SA-ADR | 0.00% | 28,000 | $177K | No change |
| OSCR Oscar Health Inc. Class A | 0.00% | 11,000 | $174K | No change |
| ARDX Ardelyx Inc. | 0.00% | 23,000 | $170K | No change |
| FOLD Amicus Therapeutics Inc. | 0.00% | 16,000 | $159K | No change |
| CCCC C4 Therapeutics Inc. | 0.00% | 28,000 | $129K | No change |
| BYND Beyond Meat Inc. | 0.00% | 19,000 | $127K | No change |
| IRWD Ironwood Pharmaceuticals Inc. | 0.00% | 13,000 | $85K | No change |
| LU Lufax Holding Ltd.-ADR | 0.00% | 15,000 | $36K | Reduce -90.0% |
Options reported separately and not counted above: SPY puts ($4.8B), IWM puts ($862.3M), IBB puts ($480.4M), MRNA puts ($154.4M), SRPT calls ($21.1M).
Other holdings (22): bonds, preferreds, convertibles and warrants · $350.1M (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| IQIYI INC (IQ 4 12/15/26) | NOTE 4.000%12/1 · principal | 163,100,000 | $162.1M | No change |
| SUNRUN INC (RUN 0 02/01/26) | NOTE 2/0 · principal | 129,146,000 | $112.4M | Reduce -1.3% |
| ZTO EXPRESS KY INC (ZTO 1.5 09/01/27) | NOTE 1.500% 9/0 · principal | 75,000,000 | $72.9M | No change |
| GRND.WS Grindr Inc. -26 | *W EXP 11/18/202 | 540,000 | $1.8M | No change |
| LUNRW Intuitive Machines Inc.-CW | *W EXP 99/99/999 | 440,965 | $299K | No change |
| SEDA.WS SDCL Edge Acq Class A -CW28 | *W EXP 99/99/999 | 866,250 | $191K | No change |
| IVCPW Swiftmerge Acquisition -CW23 | *W EXP 12/13/202 | 990,000 | $79K | No change |
| CVIIW Churchill Capital Vii -CW28 | *W EXP 02/29/202 | 200,000 | $70K | No change |
| SLDPW Decarbonization Plus -CW23 | *W EXP 12/08/202 | 405,316 | $65K | No change |
| GATEW Marblegate Acquisition -CW22 | *W EXP 08/31/202 | 1,485,000 | $55K | No change |
| CRTWF Cartica Acquisition A -28 | *W EXP 04/30/202 | 175,000 | $34K | No change |
| JWSWF Jaws Mustang Acq C -CW26 | *W EXP 01/30/202 | 200,000 | $22K | No change |
| GHIXW Gores Holding Ix -CW24 | *W EXP 01/14/202 | 166,664 | $18K | No change |
| PERCEPTION CAPITAL CORP IV | *W EXP 99/99/999 | 300,000 | $16K | No change |
| KCGI.WS Kensington Capital Acq -CW23 | *W EXP 99/99/999 | 581,400 | $15K | No change |
| BCSAW Blockchain Coinvestors Acqui | *W EXP 11/01/202 | 150,000 | $9K | No change |
| NVNWF Nvni Group Ltd.-28 | *W EXP 11/01/202 | 375,000 | $9K | No change |
| RVMDW Revolution Medicines Inc.-28 | *W EXP 12/17/202 | 120,085 | $9K | No change |
| SEPAW Sep Acquisition Corp. -CW23 | *W EXP 99/99/999 | 866,250 | $6K | No change |
| SLMWF Slam Corp.-A -CW27 | *W EXP 99/99/999 | 17,627 | $4K | No change |
| NUVWQ Holdco Nuvo Group DG Ltd. | *W EXP 05/01/202 | 200,000 | $4K | New |
| RGTIW Rigetti Computing -CW27 | *W EXP 03/02/202 | 22,675 | $3K | No change |
Total filed on the 13F, all lines: $16.9B.
Portfolio Sells Q1 2024 → Q2 2024
| PXD Pioneer Natural Resources Co. | Sold out | 0.00% | −5.55 |
| CSGP Costar Group Inc. | Sold out | 0.00% | −1.51 |
| GOOG Alphabet Inc. Class C | Reduce -46.2% | 1.99% | −1.07 |
| INSP Inspire Medical Systems Inc. | Sold out | 0.00% | −0.81 |
| VSTS Vestis Corp. | Sold out | 0.00% | −0.57 |
| GBTC Grayscale Bitcoin Trust ETF | Sold out | 0.00% | −0.51 |
| WAB Wabtec Corp. | Reduce -25.9% | 2.09% | −0.50 |
| NDAQ Nasdaq Inc. | Reduce -11.0% | 2.73% | −0.47 |
| MASI Masimo Corp. | Reduce -24.8% | 0.85% | −0.46 |
| CBRE CBRE Group Inc. Class A | Reduce -9.8% | 2.03% | −0.42 |
| SHW The Sherwin-Williams Co. | Reduce -14.1% | 1.16% | −0.41 |
| X United States Steel Corp. | Reduce -46.4% | 0.39% | −0.39 |
| CNC Centene Corp. | Reduce -16.9% | 0.87% | −0.36 |
| TRU Transunion | Reduce -5.0% | 2.70% | −0.35 |
| TMO Thermo Fisher Scientific Inc. | Reduce -7.3% | 2.46% | −0.32 |
| MA Mastercard Inc. Class A | Reduce -9.8% | 1.23% | −0.25 |
| HWM Howmet Aerospace Inc. | Reduce -25.5% | 1.19% | −0.21 |
| EVH Evolent Health Inc. Class A | Sold out | 0.00% | −0.20 |
| IONS Ionis Pharmaceuticals Inc. | Reduce -99.3% | 0.00% | −0.19 |
| COR Cencora Inc. | Reduce -27.3% | 0.33% | −0.16 |
| HIMS Hims & Hers Health Inc. | Reduce -99.4% | 0.00% | −0.15 |
| BABA Alibaba Group Holding-SP ADR | Sold out | 0.00% | −0.14 |
| APGE Apogee Therapeutics Inc. | Sold out | 0.00% | −0.12 |
| SIMO Silicon Motion Technol-ADR | Reduce -33.7% | 0.28% | −0.12 |
| HUM Humana Inc. | Reduce -98.8% | 0.00% | −0.11 |
| ARQT Arcutis Biotherapeutics Inc. | Reduce -98.5% | 0.00% | −0.10 |
| ASND Ascendis Pharma A/S | Sold out | 0.00% | −0.10 |
| ITCI Intra-Cellular Therapies Inc. | Sold out | 0.00% | −0.10 |
| RNAM Avidity Biosciences Inc. | Reduce -99.2% | 0.00% | −0.09 |
| UNH Unitedhealth Group Inc. | Reduce -4.9% | 4.97% | −0.09 |
| IMNM Immunome Inc. | Sold out | 0.00% | −0.09 |
| PACB Pacific Biosciences of Calif | Reduce -96.4% | 0.00% | −0.08 |
| SCRM Screaming Eagle Acq Class A | Sold out | 0.00% | −0.06 |
| ELEV Elevation Oncology Inc. | Reduce -7.4% | 0.06% | −0.06 |
| ADI Analog Devices Inc. | Reduce -16.5% | 1.77% | −0.06 |
| QTRX Quanterix Corp. | Reduce -83.0% | 0.01% | −0.06 |
| PCG P G & E Corp. | Reduce -45.6% | 0.07% | −0.06 |
| CZOOF Cazoo Group Ltd. | Sold out | 0.00% | −0.05 |
| BRKR Bruker Corp. | Sold out | 0.00% | −0.05 |
| GOSS Gossamer Bio Inc. | Sold out | 0.00% | −0.04 |
| ALT Altimmune Inc. | Reduce -94.1% | 0.00% | −0.03 |
| ICLR Icon PLC | Reduce -0.8% | 0.34% | −0.03 |
| PCVX Vaxcyte Inc. | Reduce -23.2% | 0.13% | −0.02 |
| PRAX Praxis Precision Medicines I | Sold out | 0.00% | −0.02 |
| AVBP Arrivent Biopharma Inc. | Sold out | 0.00% | −0.02 |
| ROIV Roivant Sciences Ltd. | Reduce -25.1% | 0.04% | −0.01 |
| ARMK Aramark | Reduce -5.0% | 3.47% | −0.01 |
| SLNO Soleno Therapeutics Inc. | Sold out | 0.00% | −0.01 |
| NVAX Novavax Inc. | Reduce -66.6% | 0.03% | −0.00 |
| LU Lufax Holding Ltd.-ADR | Reduce -90.0% | 0.00% | −0.00 |
Portfolio Buys Q1 2024 → Q2 2024
| DIS The Walt Disney Co. | New | 2.14% | +2.14 |
| AON Aon PLC Class A | Add +196.7% | 3.32% | +2.05 |
| CTLT Catalent Inc. | Add +198.0% | 2.58% | +1.71 |
| HCP Hashicorp Inc. Class A | New | 1.20% | +1.20 |
| CRM Salesforce Inc. | Add +51.0% | 4.57% | +1.03 |
| SRCL Stericycle Inc. | New | 0.90% | +0.90 |
| RVMD Revolution Medicines Inc. | Add +30.0% | 2.28% | +0.83 |
| NTRA Natera Inc. | Add +13.6% | 2.91% | +0.75 |
| LNTH Lantheus Holdings Inc. | Add +53.7% | 1.10% | +0.55 |
| AZN Astrazeneca PLC-Spons ADR | Add +65.1% | 1.13% | +0.54 |
| AGIO Agios Pharmaceuticals Inc. | Add +1.1% | 1.47% | +0.49 |
| AMGN Amgen Inc. | New | 0.44% | +0.44 |
| INTU Intuit Inc. | Add +17.1% | 2.49% | +0.39 |
| EDU New Oriental Educatio-SP ADR | Add +139.0% | 0.69% | +0.37 |
| NOW ServiceNow Inc. | Add +14.9% | 2.15% | +0.34 |
| GERN Geron Corp. | Add +124.6% | 0.43% | +0.28 |
| INSM Insmed Inc. | New | 0.23% | +0.23 |
| PTGX Protagonist Therapeutics Inc. | Add +1.8% | 1.22% | +0.22 |
| BEAM Beam Therapeutics Inc. | Add +75.4% | 1.12% | +0.22 |
| FLUT Flutter Entertainment PLC-Di | New | 0.22% | +0.22 |
| BHVN Biohaven Ltd. | Add +181.3% | 0.47% | +0.21 |
| CRSP Crispr Therapeutics AG | New | 0.17% | +0.17 |
| AMED Amedisys Inc. | Add +29.8% | 0.72% | +0.17 |
| V Visa Inc. Class A | Add +20.7% | 1.30% | +0.16 |
| CHX Championx Corp. | New | 0.16% | +0.16 |
| THC Tenet Healthcare Corp. | Add +7.8% | 0.55% | +0.15 |
| CRNX Crinetics Pharmaceuticals Inc. | Add +9840.0% | 0.13% | +0.13 |
| HES Hess Corp. | Add +5.4% | 6.03% | +0.13 |
| UTHR United Therapeutics Corp. | Add +30.0% | 0.27% | +0.12 |
| PGNY Progyny Inc. | Add +120.8% | 0.23% | +0.09 |
| CNTA Centessa Pharmaceuticals Ltd. | Add +438.0% | 0.11% | +0.08 |
| TWST Twist Bioscience Corp. | New | 0.06% | +0.06 |
| AXONICS INC | Add +64.4% | 0.15% | +0.06 |
| TECX Tectonic Therapeutic Inc. | New | 0.04% | +0.04 |
| GDS GDS Holdings Ltd. - ADR | Add +72.7% | 0.07% | +0.04 |
| SVRA Savara Inc. | Add +90.5% | 0.11% | +0.04 |
| CERE Cerevel Therapeutics Holding | Add +11.9% | 0.29% | +0.02 |
| MAC COPPER LTD | Add +160.4% | 0.03% | +0.02 |
| BDSX Biodesix Inc. | New | 0.02% | +0.02 |
| NRIX Nurix Therapeutics Inc. | New | 0.01% | +0.01 |
| VEEV Veeva Systems Inc. Class A | New | 0.00% | +0.00 |
| IMVT Immunovant Inc. | New | 0.00% | +0.00 |
| TMDX Transmedics Group Inc. | New | 0.00% | +0.00 |
| GMED Globus Medical Inc. Class A | New | 0.00% | +0.00 |
| MRUS Merus NV | New | 0.00% | +0.00 |
| DYN Dyne Therapeutics Inc. | New | 0.00% | +0.00 |
| CGC Canopy Growth Corp. | New | 0.00% | +0.00 |
| SYRE Spyre Therapeutics Inc. | Add +42.9% | 0.09% | −0.01 |
| ABNB Airbnb Inc. Class A | Add +5.8% | 1.55% | −0.04 |
| EXEL Exelixis Inc. | Add +1.6% | 3.67% | −0.13 |
Options Activity Q1 2024 → Q2 2024
| SPY SS SPDR S&P 500 ETF Trust-US | put | Reduce -22.9% | 8,900,000 | $4.8B |
| IWM iShares Russell 2000 ETF | put | New | 4,250,000 | $862.3M |
| MRNA Moderna Inc. | put | New | 1,300,000 | $154.4M |
| XBI SS SPDR S&P Biotech ETF | put | Sold out | 500,000 | $47.4Mbefore exit |
| SRPT Sarepta Therapeutics Inc. | call | New | 133,300 | $21.1M |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
Notes & Other Activity Q1 2024 → Q2 2024
| SUNRUN INC (RUN 0 02/01/26) | NOTE 2/0 · principal | Reduce -1.3% | 129,146,000 | $112.4M |
| JOYY INC (JOYY 1.375 06/15/26) | NOTE 1.375% 6/1 · principal | Sold out | 10,415,000 | $10.3Mbefore exit |
| METALS ACQUISITION LTD | *W EXP 06/15/202 | Sold out | 825,000 | $1.7Mbefore exit |
| SCRMW Screaming Eagle Acq Class A -27 | *W EXP 99/99/999 | Sold out | 333,330 | $157Kbefore exit |
| AEON BIOPHARMA INC | *W EXP 07/21/202 | Sold out | 49,995 | $72Kbefore exit |
| VSTWF Vast Solar PTY Ltd. -28 | *W EXP 07/01/202 | Sold out | 450,000 | $32Kbefore exit |
| LGVCW Lamf Global Ventures -CW23 | *W EXP 99/99/999 | Sold out | 200,000 | $20Kbefore exit |
| NUVWQ Holdco Nuvo Group DG Ltd. | *W EXP 05/01/202 | New | 200,000 | $4K |
| MVLAW Pathfinder Acq Class A -CW27 | *W EXP 02/10/202 | Sold out | 150,000 | $945before exit |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 77 | $16.9B | RVMD, EA, BBIO, PTGX, EXEL |
| Q1 2026Amended | 163 | $16.8B | EA, RVMD, AMZN, MSFT, AON |
| Q4 2025Amended | 143 | $19.2B | RVMD, MSFT, AMZN, EA, AON |
| Q3 2025Amended | 134 | $17.7B | MSFT, AON, EXEL, AMZN, NTRA |
| Q2 2025Amended | 138 | $21.9B | SPY, MSFT, NTRA, HES, AON |
| Q1 2025Amended | 139 | $18.5B | HES, MSFT, EXEL, DFS, UNH |
| Q4 2024Amended | 138 | $18.9B | HES, EXEL, UNH, DFS, NTRA |
| Q3 2024Amended | 145 | $18.0B | HES, IQV, EXEL, UNH, MSFT |
| Q2 2024Amended | 140 | $16.6B | HES, UNH, CRM, IQV, EXEL |
| Q1 2024Amended | 144 | $16.6B | HES, PXD, UNH, IQV, EXEL |